Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • The EMBO Journal (Home)
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Referee Guidelines
  • Open Access Charges

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Recommend to Librarian
  • Customer Service
  • Home
  • 17 (24)

Drosophila grim induces apoptosis in mammalian cells

Cristina Clavería, Juan Pablo Albar, Antonio Serrano, José María Buesa, José Luis Barbero, Carlos Martínez‐A, Miguel Torres
DOI 10.1093/emboj/17.24.7199 | Published online 15.12.1998
The EMBO Journal (1998) 17, 7199-7208
Cristina Clavería
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Pablo Albar
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Serrano
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José María Buesa
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Luis Barbero
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Martínez‐A
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Torres
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Cristina Clavería1,
  2. Juan Pablo Albar1,
  3. Antonio Serrano1,
  4. José María Buesa1,
  5. José Luis Barbero1,
  6. Carlos Martínez‐A1 and
  7. Miguel Torres*,1
  1. 1 Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, 28049, Madrid, Spain
  1. ↵*Corresponding author. E-mail: Mtorres{at}cnb.uam.es
View Full Text
  • Article
  • Figures & Data
  • Transparent Process
Loading

Abstract

Genetic studies have shown that grim is a central genetic switch of programmed cell death in Drosophila; however, homologous genes have not been described in other species, nor has its mechanism of action been defined. We show here that grim expression induces apoptosis in mouse fibroblasts. Cell death induced by grim in mammalian cells involves membrane blebbing, cytoplasmic loss and nuclear DNA fragmentation. Grim‐induced apoptosis is blocked by both natural and synthetic caspase inhibitors. We found that grim itself shows caspase‐dependent proteolytic processing of its C‐terminus in vitro. Grim‐induced death is antagonized by bcl‐2 in a dose‐dependent manner, and neither Fas signalling nor p53 are required for grim pro‐apoptotic activity. Grim protein localizes both in the cytosol and in the mitochondria of mouse fibroblasts, the latter location becoming predominant as apoptosis progresses. These results show that Drosophila grim induces death in mammalian cells by specifically acting on mitochondrial apoptotic pathways executed by endogenous caspases. These findings advance our knowledge of the mechanism by which grim induces apoptosis and show the conservation through evolution of this crucial programmed cell death pathway.

  • apoptosis
  • bcl‐2
  • grim
  • mitochondria
  • mouse

Introduction

Multicellular organisms eliminate unwanted or damaged cells by a regulated cell death process. Deviations from the physiological levels of cell death during adult life result in either proliferative or degenerative disorders (Thompson, 1995). Cell death is particularly relevant in several critical processes of development, such as organ and tissue shaping during morphogenesis and embryogenesis, tissue resorption during metamorphosis and neuronal selection (Jacobson et al., 1997). Cell death during development occurs in a temporally and spatially reproducible pattern and is genetically controlled, and thus is regarded as programmed cell death (PCD). Most PCD processes, independently of the origin of the death stimulus, are executed through a stereotyped pattern of cellular and biochemical events known as apoptosis (Wyllie et al., 1980). Genetic analysis of PCD in the nematode Caenorhabditis elegans identified essential elements of the basic machinery for both the regulation and execution phases of apoptotic death (Ellis et al., 1991), and showed for the first time their conservation throughout metazoan evolution (Vaux et al., 1992). Presently, endogenous and viral molecules that promote, inhibit or are required for apoptosis have been found to be conserved from nematodes to humans (McCall and Steller, 1997). Among these, the activation of a particular group of conserved sequence‐specific proteases, known as caspases (cysteine aspartases), is fundamental for the execution phase of the apoptotic programme (Nicholson and Thornberry, 1997). Apoptotic caspases can be activated in mammalian cells through at least two independent pathways: the pathway triggered by the activation of the transmembrane receptors Fas and tumour necrosis factor receptor (TNFR) (reviewed in Nagata, 1997), and a mitochondrial, bcl‐2‐sensitive pathway (reviewed in Kroemer, 1997).

Mitochondria integrate death signals from very diverse origins, such as genotoxic damage, cytotoxic stress, factor deprivation, glucocorticoid addition, heat shock and radiation. While many of such mechanisms constitute cellular responses to exogenous injury, others respond to events that operate in vivo to activate physiological PCD; however, the pathways that connect these events to the mitochondria remain unknown. Some of these pathways may involve the transcriptional activation of killer genes. In fact, even though several mammalian cell types can be induced experimentally to enter apoptosis without protein synthesis (Weil et al., 1996), transcriptional activation of specific genes is absolutely required for natural PCD in both insect and vertebrate whole embryos (Tata, 1966; Oppenheim et al., 1990; Schwartz et al., 1990; Coucouvanis and Martin, 1995) and factor‐deprived cultured neurons (Martin et al., 1988). Much of the natural cell death occurring during insect and vertebrate development is likely to be mediated by the transcriptional activation of killer genes. Recent studies in the fly Drosophila melanogaster have uncovered three novel components of the genetic programme controlling PCD, reaper, hid and grim, whose transcriptional activation precedes, induces and is necessary for PCD by apoptosis (White et al., 1994; Grether et al., 1995; Chen et al., 1996; Robinow et al., 1997). The three genes map to a single genetic complex and function as death switches that are regulated at the level of transcription. Their ectopic activation triggers apoptosis in otherwise viable cells, and their inactivation prevents apoptosis of cells that would normally undergo PCD. Interestingly, their activation not only mediates programmed apoptotic events occurring during normal development, but also the apoptosis induced in response to exogenous agents, such as ionizing radiation, to which their promoter regions respond (Nordstrom et al., 1996). Therefore, reaper, grim and hid play a pivotal role in integrating different death stimuli leading to insect cell death by apoptosis (reviewed in McCall and Steller, 1997). A similarly acting cell death regulator has not yet been identified in any vertebrate system, but reaper has been shown to induce apoptosis in an in vitro amphibian model (Evans et al., 1997).

Despite their organization in a single genetic complex, the three gene products share no sequence similarity except for the partially conserved first 14 amino acids. Cooperativity has been reported among the three genes, but grim appears to be the most efficient cell death inducer (Chen et al., 1996; Zhou et al., 1997). While many other components of PCD pathways show a high structural and functional conservation throughout evolution, no grim‐like gene has yet been isolated from any species but Drosophila, nor have conserved grim domains been described in other proteins. The mechanism of grim action also remains unknown.

Herein we demonstrate that grim induces apoptosis in 3T3 and primary mouse fibroblasts through a bcl‐2‐sensitive mechanism that triggers endogenous apoptotic caspases. Our findings show that the endogenous mitochondrial mammalian apoptotic machinery recognizes and responds correctly to Drosophila grim. These results strongly argue for the existence of endogenous grim homologues that may account for transcription‐dependent PCD regulation in vertebrates.

Results

Grim induces death in mouse 3T3 fibroblasts

To test its ability to induce apoptosis in mammalian cells, we transiently expressed Drosophila grim in mouse 3T3 fibroblasts. The grim‐coding sequence was inserted into a vector that provided doxycycline‐inducible synchronous expression of the sequences inserted. To characterize grim expression, we developed an antiserum against the whole recombinant protein purified from Escherichia coli. Western blots detected a band of the expected size, specific for extracts from transfected cells, which coincided with the size of the endogenous Drosophila protein and of the recombinant grim protein purified from E.coli (Figure 1I). An additional smaller band specific for transfected cells was also observed. A similar downshift was observed for both bands in extracts from cells transfected with a truncated grim mutant lacking amino acids 2–14 (see below) (Figure 1I). This confirms that the detected bands correspond to the transfected grim and shows that the smaller form results from partial cleavage of the protein at its C‐terminus. However, the smaller band was not observed when the concentration of the serine/cysteine protease general inhibitor phenylmethylsulfonyl fluoride (PMSF), included in the lysis buffer, was increased from the standard 1 mM to 2 mM (Figure 1I). We therefore conclude that grim proteolysis is taking place after cell lysis by a strong proteolytic activity present in the extracts. Immunofluorescence was used to identify grim‐expressing cells in transfected cultures. We found that cells with high grim levels show morphological traits characteristic of various phases of apoptosis including loss of substrate attachment, membrane blebbing and cytoplasmic loss (Figure 1A–H). Initially, when the predominant feature was membrane blebbing, nuclei were still negative for TUNEL staining (Figure 1B and F). Later, grim‐expressing cells adhered to neighbouring cells, showed nuclear DNA condensation and became positive for TUNEL staining, indicating DNA fragmentation (Figure 1C, G and J). Finally, cytoplasm and nuclei disaggregated completely into apoptotic bodies, which remained strongly positive both for grim and TUNEL (Figure 1D, H and K).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Grim induces apoptosis in mouse 3T3 fibroblasts. The pictures show immunofluorescent detection of grim expression and DNA fragmentation by TUNEL staining. Grim expression is shown in red, TUNEL staining in green and Hoechst‐stained nuclei in blue. (A and E) Grim‐positive cells presenting apoptotic morphology (arrowheads) and a matching DIC + fluorescence‐composed image, respectively. (B–D) Cells representative of the successive steps of the apoptotic process. (F, G and H) DIC + fluorescence‐composed images matching respectively, (B), (C) and (D). (J and K) DIC + Hoechst‐composed images matching, respectively, (G) and (H). (I) Western blot detection of grim in whole protein extracts from Drosophila embryos (d), grim protein purified from E.coli extracts (p), and extracts from 3T3 fibroblasts transfected with either full‐length grim (g), grimΔ (gΔ) or the corresponding empty vectors (c) from cells lysed in either 1 or 2 mM PMSF as indicated.

To facilitate quantitation of the death induction effect, grim was co‐transfected with the same expression vector driving LacZ expression. Grim expression resulted in the elimination of two‐thirds of the transfected cells during the 24 h of culture after the addition of doxycycline (Figures 2A, and 3A and B). The reduction in blue cells specifically affected the high‐LacZ‐expressing cell class; >90% of cells in this class were killed in grim‐transfected cultures (Figures 2B, and 3A and B). In agreement with the observed cell death effect, grim‐transfected cultures showed a high percentage of blue cells with a characteristic apoptotic morphology (Figure 2C). All experiments were performed maintaining cells in 10% serum; lowering the serum concentration to 0.1% did not reduce the percentage of surviving cells (not shown). We conclude that grim kills 3T3 cells through apoptosis induction in a serum‐insensitive manner.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Quantitation of cell death by LacZ co‐transfection and time‐lapse videomicroscopy. The frequency of total blue cells (A) or intense blue cells (B) was measured in co‐transfections of LacZ vector plus empty (control), grim or grimΔ expression vectors. The moment of doxycycline addition (18 h after transfection) was taken as t0 in the graphs. (C) The frequency of cells with apoptotic morphology within the blue cell class. Time‐lapse videorecording was used for the observation of the transfected cultures. Initiation of membrane blebbing invariably led to cell death; cell death events were therefore scored at the initiation of blebbing (D). Average total cell numbers during filming time were 245, 258 and 239 for control, grim and grimΔ, respectively. (E) The average blebbing time for wild‐type and mutant grim forms.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Grim‐induced apoptosis requires caspase activity. The pictures show X‐Gal staining of 3T3 fibroblast cultures transfected with LacZ‐expressing vector and either empty or grim‐expressing vector as indicated. Vectors expressing p35 or OpIAP under the control of the elongation factor‐1 (EF‐1) promoter were co‐transfected, when indicated, in a 1:1 ratio to the grim‐expressing vector. After transfection, 50 μM zVAD.fmk, DEVD.cho or YVAD.cho was added to the culture medium as indicated. Cells were processed for LacZ staining 24 h after doxycycline addition.

The conserved N‐terminal region of grim is not necessary for apoptosis induction or execution

The only conserved sequence found in grim is a 14 amino acid N‐terminal motif, also present in hid and reaper (Chen et al., 1996). To test the relevance of this motif in our system, a truncated form of grim lacking amino acids 2–14 was expressed (grimΔ, Figure 1I). The mutant form retained most of the grim killing ability, but cells appeared to tolerate slightly higher levels of the mutant protein without entering apoptosis (Figure 2A–C). We used time‐lapse videomicroscopy to characterize and compare the death‐inducing effects of wild‐type and mutant grim forms. Video analysis showed that between 4 and 10 h after doxycycline addition, the rate of cell death in grim‐transfected cultures was 14 times higher than in control‐transfected cultures, and demonstrated no differences between the wild‐type and mutant forms (Figure 2D). In addition, we determined the mean length of the blebbing period as a reference measure for the duration of the execution phase of apoptosis induced by both transfected forms. Again, no differences were observed between the mutant and wild‐type forms (Figure 2E). We conclude that the conserved N‐terminal domain is not required for either the initiation or the execution of apoptosis by grim. The same conclusion was reported when a similar grim truncation mutant was introduced in insect cells (Vucic et al., 1998).

Caspase activity is required to execute grim‐induced cell death

To test the involvement of caspases in grim‐induced death, we used specific inhibitors together with LacZ co‐transfection. Addition of the cell‐permeable broad specificity caspase inhibitor zVAD.fmk to the culture medium rescued all the LacZ‐expressing cells from grim‐induced death (Figures 3E and F, and 4A). At the same time and in agreement with previous evidence from insects (Chen et al., 1996), the wide‐range natural caspase inhibitor p35 also rescued cells from grim‐induced death (Figures 3G and 4A). In contrast, the group II‐caspase inhibitor DEVD.cho only showed a residual rescuing capacity (Figures 3D and 4A). In agreement with this result, the natural group II caspase inhibitor OpIAP also showed a very limited rescuing capacity (Figures 3C and 4A). Increasing the molar ratio of OpIAP‐expressing vector up to 3:1 versus the grim‐expressing vector did not improve the viability of grim‐transfected cells (data not shown). The group I caspase inhibitor YVAD.cho was unable to prevent grim‐induced death, either alone or in combination with DEVD.cho (Figures 3H and L, and 4A). Increasing YVAD.cho and DEVD.cho concentrations up to 250 μM did not elicit cell rescue by these inhibitors (data not shown). Western blot analysis showed that transfected grim was expressed at high levels in cultures that were either incubated or co‐transfected with the different inhibitors (Figure 4B), confirming that inhibition of caspase activity counteracts apoptosis execution by blocking a step downstream of grim action.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Quantification of cell rescue capacity of natural and synthetic caspase inhibitors. The bar graph (A) shows the survival ratio of cells transfected under the experimental conditions shown in Figure 3. The survival ratio was calculated as the ratio between the frequency of blue cells found in grim‐ and empty vector‐transfected cultures in each experimental condition. Western blot detection of p35‐ and OpIAP‐transfected proteins is shown above. (B) Western blot detection of grim protein in 3T3 fibroblasts transfected under control conditions and cultured in the presence of the different caspase inhibitors or co‐transfected with either p35 or OpIAP, as indicated.

The broad specificity caspase inhibitors zVAD.fmk and p35 prevented grim cleavage under conditions that allowed its proteolysis in cell extracts (Figure 4B). This result suggests that an endogenous caspase is responsible for grim cleavage. The similar shift observed in Western blot bands for both the cleaved and intact forms of the protein in the N‐terminal deletion mutant showed that the cleaved portion of the protein was the C‐terminus (Figure 1I). Three clustered aspartate residues near the grim C‐terminus (positions 126, 128 and 129) could then be used by a caspase as a target sequence. The downshift predicted by digestion at these sites is between 1 and 1.3 kDa; however, the observed size for the short form is ∼4 kDa less than that observed for the intact protein. Nevertheless, we have observed that C‐terminal deletions of the protein provoke downshifts greater than expected, which are in the range of the observed downshift for the proteolysed form of the protein (data not shown). These results show that besides activating caspases, grim itself can be processed as a consequence of their proteolytic activity. Even though OpIAP and DEVD.cho did not block grim‐induced apoptosis, they were both functionally active in repressing endogenous caspases in either treated or transfected cells, since they prevented grim cleavage (Figure 4B). Therefore, it is likely that caspases insensitive to OpIAP and/or DEVD.cho were sufficient to achieve grim‐induced apoptosis.

Interestingly, zVAD‐treated cells did initiate apoptosis but were blocked at the blebbing stage, did not complete the apoptotic programme during the observation time, remained intact in the culture dish, did not become TUNEL‐positive and did not suffer nuclear disaggregation (Figure 3I and J). The same cellular phenotype has been described previously for cells in which the apoptosis induced by c‐myc, E1A and Bak had been blocked by zVAD (McCarthy et al., 1997). In contrast, grim‐expressing p35‐rescued cells continued to divide at a similar rate to that of control p35‐transfected cells and did not show membrane blebbing (Figure 3K), suggesting that p35 may inhibit apoptotic processes independent of the activity of caspases sensitive to zVAD inhibition. These results demonstrate that grim induces apoptosis by activating endogenous mammalian caspases.

Grim does not induce unspecific toxicity in mammalian cells

Overexpressed exogenous molecules can generate unspecific toxicity leading to a stress response, including apoptosis induction. In order to determine whether the observed induction of apoptosis by grim was originated through an unspecific toxic effect, we analysed two basic metabolic parameters of grim‐transfected p35‐rescued cells. We measured DNA and protein synthesis by the incorporation of [3H]thymidine and [35S]methionine. In spite of them expressing very high levels of grim (Figure 4B), we found that they synthesized DNA and protein at the same rates as mock‐transfected cells (Figure 5). Interestingly, simply p35‐transfected cells showed protein synthesis rates similar to control and p35+grim‐transfected cells, but showed very low levels of thymidine incorporation, suggesting that p35 inhibits DNA synthesis and that grim reverses this effect. Since caspase inhibition by p35 involves its cleavage, caspase activation by grim may lower the effective amount of p35, thereby allowing normal DNA synthesis rates. These results show that, as long as apoptosis is blocked by p35, even high levels of grim protein do not affect basic parameters of cell metabolism such as DNA or protein synthesis. We conclude that grim kills mouse fibroblasts by specifically inducing apoptosis pathways.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Grim‐expressing p35‐rescued cells do not show symptoms of cellular stress. Graphs (A) and (B) show, respectively, the [3H]thymidine and [35S]methionine incorporation rates by cells transfected with the LacZ‐expressing vector and p35 and grim empty vectors (control), p35‐expressing vector and grim empty vector (p35), or p35‐ and grim‐expressing vectors (grim + p35). The horizontal axis shows the number of cells lipofected in each assayed culture well. Cells received 12 h pulses of either isotope starting 30 h after lipofection. Serum‐starved and cycloheximide‐treated cells were used as negative controls for the incorporation of [3H]thymidine and [35S]methionine, respectively. Replica wells were stained for LacZ to determine the actual transfection level under each experimental condition. The percentage of transfected cells did not vary among the different cell concentrations and were as follows: control, 52 ± 4%; p35, 46 ± 6%; grim + p35, 49 ± 5%. CHX, cycloheximide.

Death induction by grim is inhibited by bcl‐2 and is independent of Fas signalling or p53 activity

Although the Fas pathway involves activation of an extracellular signalling mechanism, it has been shown to mediate the apoptosis‐inducing effect of c‐myc in fibroblasts by an autocrine mechanism (Hueber et al., 1997). To test the implication of the Fas–FasL pathway in grim death induction, we transfected it into primary mouse embryo fibroblasts (MEFs) derived from lpr (Fas‐deficient) mice. We found that the ability of grim to kill 3T3 fibroblasts was conserved in control wild‐type MEFs and that cell survival was not increased when grim was transfected into lpr/lpr primary fibroblasts (Figure 6A). Fas signalling is, therefore, not required for grim pro‐apoptotic activity, suggesting that grim activates a mitochondrial death pathway.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Death induction by grim is counteracted by bcl‐2 expression and does not require either Fas signalling or p53 activity. (A) The survival ratio of grim‐transfected p53‐ (p53 −/−) or Fas‐ (lpr/lpr) deficient MEFs and the respective control MEFs of the same genetic background. (B) The survival ratio of 3T3 fibroblasts co‐transfected with grim and LacZ expression vectors, and either empty or hbcl‐2‐pEF‐BOS expression vectors. The grim‐expressing vector was included at different molar ratios to the bcl‐2‐expressing vector as indicated. The survival ratio was calculated as described in the legend to Figure 4. Western blot detection of bcl‐2 and grim proteins in each experimental condition is shown above the corresponding bars. Both proteins were detected on the same filter by consecutive incubation with bcl‐2 and grim antibodies, respectively.

One of the endogenous pathways leading to mitochondrial‐mediated cell death is that triggered by p53 activation in response to DNA damage (Clarke et al., 1993; Lowe et al., 1993; Polyak et al., 1997). We transfected grim into p53 null mutant MEFs to determine whether p53 mediated grim‐induced apoptosis. Cell viability was not increased in p53‐deficient primary fibroblasts as compared with control wild‐type MEFs (Figure 6A), showing that grim does not require p53 activity to induce apoptosis.

Mitochondrial pathways leading to apoptosis induction are generally inhibited by the anti‐apoptotic protein bcl‐2. To test whether grim apoptosis induction was sensitive to bcl‐2 levels, we co‐transfected it with grim into 3T3 fibroblasts. Overexpression of bcl‐2 significantly reduced grim killing efficiency, increasing the relative viability of grim‐transfected cells, without affecting the efficiency of grim expression (Figure 6B). The bcl‐2 rescue effect was dose sensitive, and was suppressed by increasing the amount of grim‐expressing vector (Figure 6B). These results show that the balance between grim and bcl‐2 determines whether or not the cell enters into apoptosis, and suggest that grim activates death by interacting with components of the mitochondrial pathways.

Grim progressively localizes in mitochondria during apoptosis progression

The sensitivity of the grim‐induced death to bcl‐2 levels suggested that grim acts by activating a mitochondrial pathway. To determine the site of grim action, we explored its subcellular localization in transfected cells that do not yet show morphological symptoms of apoptosis. Pre‐apoptotic fibroblasts simultaneously show grim in two different cytoplasmic localizations: diffuse cytosolic and a punctate pattern. However, while cells simply grim‐transfected showed almost exclusively a cytosolic localization, cells treated with zVAD.fmk showed predominantly the punctate pattern (Figure 7). The same pattern is observed in grim‐expressing p35‐rescued cells (data not shown). Co‐localization of grim protein with a mitochondrial‐specific antibody showed that the punctate pattern corresponded to mitochondria (Figure 7). In contrast to the pre‐apoptotic cells, blebbing cells simply grim‐transfected, while still presenting the diffuse localization, also consistently showed the mitochondrial localization (Figure 7). Again, zVAD‐blocked blebbing cells showed almost exclusively a mitochondrial expression pattern (Figure 7). We conclude that grim localizes initially in the cytoplasm but accumulates progressively in the mitochondria, correlating with apoptosis progression. It is possible that grim translocation to mitochondria is the event that triggers the apoptotic pathway. In that case, the increased mitochondrial localization of grim in zVAD‐treated cells would be the result of the apoptosis blockade by zVAD at a point downstream of grim incorporation in the mitochondria.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Grim subcellular localization. Confocal optical sections detecting the subcellular localization of grim (red), mitochondria (green) and co‐localization of both signals (orange–yellow), as indicated. Stainings were performed on grim‐transfected cells in the absence or presence of zVAD.fmk, as indicated.

Discussion

Our results show that the novel cell death gene grim, recently isolated from Drosophila, induces apoptosis in mouse fibroblasts. As reported in insects (Chen et al., 1996; Vucic et al., 1998), the apoptotic process induced by grim is executed through caspase activity. One possible explanation for this result would be that grim kills mammalian cells by an unspecific toxicity effect resulting in caspase activation. Such a mechanism would imply that p35‐rescued cells are doomed cells that cannot die because their apoptosis execution machinery is blocked. However, p35‐rescued cells continue dividing normally and do not show reduction in DNA or protein synthesis. Therefore, grim acts by specifically inducing apoptotic pathways, rather than by an unspecific toxicity effect on mammalian cells. We found that the protein is present in a cytoplasmic diffuse localization and progressively translocates to mitochondria during apoptosis progression. Grim may therefore operate by activating death pathways transduced by the mitochondria, but we cannot exclude that the cytosolic form of grim might be required for, or enhance events of the apoptosis induction or execution phase. It is then possible that mitochondrial components of the mammalian cellular apoptotic machinery recognize the Drosophila grim protein and respond by activating the apoptotic programme, as they would after the proper endogenous stimulus. In good agreement with this view, grim action is counteracted by the overexpression of the anti‐apoptotic factor bcl‐2, which generally inhibits all mitochondrial death pathways. bcl‐2 inhibits grim‐induced death in a dose‐dependent manner, suggesting that they mutually antagonize to either promote or inhibit caspase activation. A bcl‐2‐like molecule has not yet been isolated in Drosophila, but mammalian and nematode members of this family have been shown to rescue ced‐3‐ and reaper‐induced apoptosis in cultured fly cells (Hisahara et al., 1998). One possibility is that grim promotes cytochrome c release from the mitochondria, as has been shown for reaper in an in vitro amphibian system (Evans et al., 1997). In our hands, however, reaper does not induce apoptosis in mouse fibroblasts (C.Clavería and M.Torres, unpublished), arguing for a mechanism of action or regulation different from that of grim.

We also found that grim is susceptible to in vitro proteolysis by a caspase activity triggered during the apoptotic process. As grim is responsible for caspase activation, its processing by caspases may constitute a regulatory loop. This loop may function as either a positive or a negative feedback loop that controls grim activity during physiological PCD. Although we have no evidence for the operation of this mechanism in vivo we cannot exclude the possibility of its relevance under as yet unexplored physiological conditions.

Our results show that the activity of caspases insensitive to OpIAP, DEVD.cho and YVAD.cho is sufficient to execute the apoptosis induced by grim. Caspase 9, which has been shown to transduce apoptotic mitochondrial signals (Li et al., 1997; Hu et al., 1998; Pan et al., 1998), may be one of those activated by mitochondrial grim. Nevertheless, group II caspases are activated as well, since grim cleavage is inhibited by caspase inhibitors specific for this group and we cannot exclude that activation of group II caspases may also serve to execute grim‐induced apoptosis. Inhibitor of apoptosis proteins (IAPs), the natural inhibitors of group II caspases, have been shown to inhibit apoptosis by directly binding to grim, reaper and hid in a lepidopteran cell line (Vucic et al., 1997, 1998). In contrast, we observe that neither OpIAP nor DEVD block grim‐induced death. Our results, nevertheless, show that group II caspases are activated, suggesting that some of the grim‐induced caspase activation cascades are similar between mouse fibroblasts and cultured lepidopteran cells, whereas others may differ. It is possible that the particular caspase activation cascade triggered by grim depends more on the cell type in which it is expressed rather than on an intrinsic specificity of its action.

Grim expression in mammalian cells may mimic the activation of endogenous killer genes in response to different death stimuli that are transduced through mitochondrial pathways such as factor deprivation. It is important to consider that grim induces death in a completely autonomous manner and it is not affected by high serum levels. This contrasts with the observation that death induction by other regulatory molecules such as c‐myc, E1A, Bak, c‐fos, E2F or BRCA‐1 is enhanced by serum deprivation (Evan et al., 1992; Rao et al., 1992; Smeyne et al., 1993; Chittenden et al., 1995; Shao et al., 1996; Bossy‐Wetzel et al., 1997) and is blocked by specific serum components (Harrington et al., 1994). Insensitivity to serum deprivation suggests that grim may act either independently or downstream of the checkpoints at which the cell integrates internal and external signals to determine its entry into apoptosis. This view is in agreement with a grim action downstream in the pathway of factors that promote cell survival during in vitro culture or normal development.

One of the most striking observations concerning the role of Drosophila reaper is its activation upon irradiation of fly embryos (Nordstrom et al., 1996). In addition, flies bearing a deletion of reaper, hid and grim are able to withstand increased doses of irradiation without entering apoptosis. These observations situate these genes in the pathways responding to radiation‐induced cell damage. In mammalian cells, this pathway can be transduced by p53, which, in response to DNA damage, activates the transcription of factors that promote the production of reactive oxygen species (Polyak et al., 1997). Our results show that grim action does not require p53 activity; however, we cannot exclude that endogenous grim‐like molecules may be transcriptionally activated by p53 in response to DNA damage. While reaper promoter regions that mediate transcriptional activation in response to UV radiation have been identified in the fly, it is not known how this activation is achieved. It is likely that regulators, responding to cellular damage as p53 does in mammalian cells, activate reaper promoter transcription in Drosophila; however, a p53 homologue has not yet been identified in the fly.

Altogether, our results strongly argue for the existence of mammalian homologues of grim that may act similarly to their insect counterpart, thus accounting for transcription‐dependent PCD in mammals. We currently are attempting to clone grim mammalian homologues to determine their involvement in mammalian PCD.

Materials and methods

Expression vectors

Grim‐coding sequences were obtained by RT–PCR from Canton‐S 12–24 h Drosophila embryos using primers pairs G1–G3 for grim and G2–G3 for grimΔ: G1, TTCCTTCCGCGGCCGCCATGGCCATCGCCTATTTCAT; G2, TTCCTTCCGCGGCCGCCATGGCCAGAAGCTATCAGCA; G3, CGGGATCCTTAGTTCTCCTTGGAGGTG. Primers introduced NcoI–BamHI sites that were used to clone the fragments in pET‐11d (Novagen, Abingdon, UK). Sequencing confirmed the published coded protein sequence (Chen et al., 1996). A novel expression vector was constructed from the retroviral vector pBPSTR1 (Paulus et al., 1996) by substitution of tTA for rtTA. LacZ‐, grim‐ and grimΔ‐coding sequences were cloned into the responding cassette of the new vector and sequenced again before their use for lipofection. Human bcl‐2‐ and baculovirus OpIAP‐ and p35‐coding fragments were cloned in the pEF‐BOS expression vector (Mizushima and Nagata, 1990).

Cell culture and lipofection

NIH‐3T3 fibroblasts were cultured in Dulbecco‘s modified Eagle's medium (DMEM) supplemented with 10% newborn calf serum. Cells were lipofected as recommended by the manufacturer (Gibco, Gaithersburg, MD). For co‐transfections, the different expression or empty plasmids were added at equal molar ratios, except when indicated. At 18 h after lipofection, doxycycline was added to a final concentration of 2 μg/ml. At the indicated times, cells were fixed in 0.2% glutaraldehyde, washed in phosphate‐buffered saline (PBS) and X‐gal‐stained following standard protocols.

Measurement of DNA and protein synthesis

Cells were seeded in 96‐well culture plates and lipofected with the different expression vectors. For thymidine incorporation, 1 μCi of [methyl‐3H]thymidine (sp. act. 2.0 Ci/mmol, Amersham) was added per well 30 h after lipofection. Incorporation of radiolabelled thymidine was analysed 12 h later. Starved replicas were totally deprived of serum 12 h before labelling started. For methionine incorporation, 1 μCi of [35S]methionine (sp. act. >1000 Ci/mmol, Amersham) was added per well 30 h after lipofection. A period of 12 h of incorporation was allowed before measurement of protein synthesis. Replicas were assayed in the presence of 10 μg/ml cycloheximide. The results from three independent experiments for each condition and cell concentration were averaged.

Antibodies

The rabbit anti‐grim antibody was obtained against the full‐length grim protein purified from E.coli extracts. The rabbit anti‐OpIAP antibody was obtained against a synthetic peptide corresponding to OpIAP amino acids 65–81 coupled to keyhole limpet hemocyanin (KLH). In both cases, rabbits were immunized according to standard protocols by multiple intradermic injections. The total IgG fraction from grim antiserum was purified on a protein G‐coupled affinity column by FPLC. Anti‐hbcl‐2 mouse monoclonal antibody was purchased from DAKO (Glostrup, Denmark). Chicken anti‐p35 antiserum was purchased from Promega (Madison, WI). Anti‐mitochondrial antibodies were obtained from the serum of a patient with primary biliary cirrhosis, shown to recognize the E2 polypeptide of the mammalian mitochondrial pyruvate dehydrogenase complex (G.Roy, personal communication).

Immunofluorescence and TUNEL assay

For immunofluorescence and TUNEL, cells were cultured in microscope slide chambers (Cultek). Cells were washed in PBS, fixed in 4% paraformaldehyde for 15 min at room temperature, pre‐incubated in 10% goat serum, 0.1% Tween‐20 in PBS for 1 h, incubated in 10 μg/ml anti‐grim IgG for 1 h, washed three times in PBS‐Tween and incubated for 1 h in Cy3‐conjugated anti‐rabbit secondary antibody (Jackson ImmunoResearch, West Grove, PA). TUNEL was performed using the MEBSTAIN Apoptosis kit as recommended by the manufacturer (Immunotech) and developed with streptavidin–fluorescein. For double mitochondrial and grim staining, anti‐mitochondrial serum was used as a primary antibody at a 1:1000 dilution and revealed with an anti‐human Cy2‐conjugated secondary antibody (Amersham) diluted 1:400, and anti‐grim IgGs were revealed with biotinylated anti‐rabbit secondary antibodies and streptavidin–Cy3. Optical sections where obtained using an Ar–Kr laser and a TCS‐NT Leica confocal imaging systems.

Western blot

Transfected cells were lysed 24 h after doxycycline addition by incubating for 30 min at 4°C in SDS sample buffer in the presence of either 1 or 2 mM PMSF. Proteins were separated by SDS–15% PAGE and transferred to membranes which were then probed with the following antibodies: anti‐grim, 3 μg/ml total IgG; anti‐hbcl‐2 monoclonal antibody diluted 1:1000; anti‐p35 whole serum diluted 1:1000; and anti‐OpIAP whole serum diluted 1:300. In all cases, sample loading was corrected according to the percentage of blue cells observed, such that the signal obtained is normalized for the effective number of transfected cells in each experimental condition.

Time‐lapse videomicroscopy

Cells were maintained in a 37°C chamber in HEPES‐buffered culture medium and recorded with a digital video camera controlled by a computerized support. Time‐lapse video was controlled by Scion‐image (NIH‐image for PC) software, set to record one image every 30 s for 6 h. Digital videos were mounted and viewed for a total duration of 1 min (360×).

Mouse strains

MEFs were prepared by standard protocols from 13.5 day post‐coitum from p53 −/− (Donehower et al., 1992) and lpr/lpr mouse embryos and from embryos of their respective similar genetic backgrounds. MEFs were lipofected two passages after the first plating.

Acknowledgements

We thank Teresa Merino, Maria Isabel García and Lucio Gómez for excellent technical help. We appreciate very helpful comments on the manuscript from Ana Carrera, Raif Geha, Douglas Green, David R.Jones, Isabel Mérida, Ginés Morata and Hermann Steller. We thank Sonsoles Campuzano, Marco Milán and Natalia Azpiazu for their help with fly stocks and mRNA, Luis Rodríguez‐Borlado for help with the FACS, Alexandra Bras, Ana Carrera, Jose Alberto García‐Sanz, Manolo Izquierdo and Isabel Mérida for very helpful discussions during the experimental work, and Catherine Mark for corrections to the manuscript. Finally, we are grateful to Garbiñe Roy for providing the anti‐mitochondrial antibody. C.C. is a recipient of a pre‐doctoral fellowship from the ‘Fundación Ramón Areces’. The Department of Immunology and Oncology was founded and is supported by the Spanish Research Council (CSIC) and Pharmacia & Upjohn.

References

  1. ↵
    Bossy‐Wetzel E, Bakiri L and Yaniv M (1997) Induction of apoptosis by the transcription factor c‐Jun. EMBO J, 16, 1695–1709.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Chen P, Nordstrom W, Gish B and Abrams JM (1996) grim, a novel cell death gene in Drosophila. Genes Dev, 10, 1773–1782.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC (1995) Induction of apoptosis by the Bcl‐2 homologue Bak. Nature, 374, 733–736.
    OpenUrlCrossRefPubMed
  4. ↵
    Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH (1993) Thymocyte apoptosis induced by p53‐dependent and independent pathways. Nature, 362, 849–852.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Coucouvanis E and Martin GR (1995) Signals for death and survival: a two‐step mechanism for cavitation in the vertebrate embryo. Cell, 83, 279–287.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA,Jr, Butel JS and Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215–221.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Ellis RE, Yuan JY and Horvitz HR (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol, 7, 663–698.
    OpenUrlCrossRefWeb of Science
  8. ↵
    Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992) Induction of apoptosis in fibroblasts by c‐myc protein. Cell, 69, 119–128.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Evans EK, Kuwana T, Strum SL, Smith JJ, Newmeyer DD and Kornbluth S (1997) Reaper‐induced apoptosis in a vertebrate system. EMBO J, 16, 7372–7381.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Grether ME, Abrams JM, Agapite J, White K and Steller H (1995) The head involution defective gene of Drosophila melanogaster functions in programmed cell death. Genes Dev, 9, 1694–1708.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Harrington EA, Bennett MR, Fanidi A and Evan GI (1994) c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J, 13, 3286–3295.
    OpenUrlPubMed
  12. ↵
    Hisahara S, Kanuka H, Shoji S, Yoshikawa S, Okano H and Miura M (1998) Caenorhabditis elegans anti‐apoptotic gene ced‐9 prevents ced‐3‐induced cell death in Drosophila cells. J Cell Sci, 111, 667–673.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Hu Y, Benedict MA, Wu D, Inohara N and Nunez G (1998) Bcl‐XL interacts with Apaf‐1 and inhibits Apaf‐1‐dependent caspase‐9 activation. Proc Natl Acad Sci USA, 95, 4386–4391.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Hueber AO, Zorning M, Lyon D, Suda T, Nagata S and Evan GI (1997) Requirement for the CD95 receptor–ligand pathway in c‐Myc‐induced apoptosis. Science, 278, 1305–1309.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Jacobson MD, Weil M and Raff MC (1997) Programmed cell death in animal development. Cell, 88, 347–354.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Kroemer G (1997) The proto‐oncogene Bcl‐2 and its role in regulating apoptosis. Nature Med, 3, 614–620.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X (1997) Cytochrome c and dATP‐dependent formation of Apaf‐1/caspase‐9 complex initiates an apoptotic protease cascade. Cell, 91, 479–489.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993) p53 is required for radiation‐induced apoptosis in mouse thymocytes. Nature, 362, 847–849.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG and Johnson EM,Jr (1988) Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol, 106, 829–844.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    McCall K and Steller H (1997) Facing death in the fly: genetic analysis of apoptosis in Drosophila. Trends Genet, 13, 222–226.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    McCarthy NJ, Whyte MKB, Gilbert CS and Evan GI (1997) Inhibition of Ced‐3/ICE‐related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl‐2 homologue Bak. J Cell Biol, 136, 215–227.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Mizushima S and Nagata S (1990) pEF‐BOS, a powerful mammalian expression vector. Nucleic Acids Res, 18, 5322.
    OpenUrlFREE Full Text
  23. ↵
    Nagata S (1997) Apoptosis by death factor. Cell, 88, 355–365.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    Nicholson DW and Thornberry NA (1997) Caspases: killer proteases. Trends Biochem Sci, 22, 299–306.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Nordstrom W, Chen P, Steller H and Abrams JM (1996) Activation of the reaper gene during ectopic cell killing in Drosophila. Dev Biol, 180, 213–226.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    Oppenheim RW, Prevette D, Tytell M and Homma S (1990) Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of death genes. Dev Biol, 138, 104–113.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Pan G, O'Rourke K and Dixit VM (1998) Caspase‐9, Bcl‐XL, and Apaf‐1 form a ternary complex. J Biol Chem, 273, 5841–5845.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Paulus W, Baur I, Boyce FM, Breakefield XO and Reeves SA (1996) Self‐contained, tetracycline‐regulated retroviral vector system for gene delivery to mammalian cells. J Virol, 70, 62–67.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B (1997) A model for p53‐induced apoptosis. Nature, 389, 300–305.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19‐kDa and Bcl‐2 proteins. Proc Natl Acad Sci USA, 89, 7742–7746.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Robinow S, Draizen TA and Truman JW (1997) Genes that induce apoptosis: transcriptional regulation in identified, doomed neurons of the Drosophila CNS. Dev Biol, 190, 206–213.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    Schwartz LM, Kosz L and Kay BK (1990) Gene activation is required for developmentally programmed cell death. Proc Natl Acad Sci USA, 87, 6594–6598.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Shao N, Chai YL, Shyam E, Reddy P and Rao VN (1996) Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene, 13, 1–7.
    OpenUrlPubMedWeb of Science
  34. ↵
    Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T and Morgan JI (1993) Continuous c‐fos expression precedes programmed cell death in vivo. Nature, 363, 166–169.
    OpenUrlCrossRefPubMed
  35. ↵
    Tata JR (1966) Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture. Dev Biol, 13, 77–94.
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456–1462.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Vaux DL, Weissman IL and Kim SK (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bcl‐2. Science, 258, 1955–1957.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Vucic D, Kaiser WJ, Harvey AJ and Miller LK (1997) Inhibition of Reaper‐induced apoptosis by interaction with inhibitor of apoptosis proteins (IAPs). Proc Natl Acad Sci USA, 94, 10183–10188.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Vucic D, Kaiser WJ and Miller LK (1998) Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM. Mol Cell Biol, 18, 3300–3309.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Weil M, Jacobson MD, Coles HS, Davies TJ, Gardner RL, Raff KD and Raff MC (1996) Constitutive expression of the machinery for programmed cell death. J Cell Biol, 133, 1053–1059.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    White K, Grether ME, Abrams JM, Young L, Farrell K and Steller H (1994) Genetic control of programmed cell death in Drosophila. Science, 264, 677–683.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Wyllie AH, Kerr JF and Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol, 68, 251–306.
    OpenUrlCrossRefPubMed
  43. ↵
    Zhou L, Schnitzler A, Agapite J, Schwartz LM, Steller H and Nambu JR (1997) Cooperative functions of the reaper and head involution defective genes in the programmed cell death of Drosophila central nervous system midline cells. Proc Natl Acad Sci USA, 94, 5131–5136.
    OpenUrlAbstract/FREE Full Text
  • Copyright © 1998 European Molecular Biology Organization
View Abstract
Previous Article in this IssueNext Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

In this Issue
Volume 17, Issue 24
15 December 1998
17 (24)
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Acknowledgements
    • References
  • Figures & Data
  • Transparent Process

Related Content

More Article

  • Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress
    Jonathan Chang, Brandi N Davis‐Dusenbery, Risa Kashima, Xuan Jiang, Nisha Marathe, Roberto Sessa, Justin Louie, Wei Gu, Giorgio Lagna, Akiko Hata
    The EMBO Journal 32: 3192-3205
  • USP10 inhibits genotoxic NF‐κB activation by MCPIP1‐facilitated deubiquitination of NEMO
    Jixiao Niu, Yuling Shi, Jingyan Xue, Ruidong Miao, Shengping Huang, Tianyi Wang, Jiong Wu, Mingui Fu, Zhao‐Hui Wu
    The EMBO Journal 32: 3206-3219
  • Large cargo transport by nuclear pores: implications for the spatial organization of FG‐nucleoporins
    Li‐Chun Tu, Guo Fu, Anton Zilman, Siegfried M Musser
    The EMBO Journal 32: 3220-3230
More Article

Related Articles

Cited By...

Request Permissions

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office
  • Privacy Policy

Authors & Referees

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Recommend to Librarian
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1460-2075

Copyright© 2019 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.